Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-α in human epidermoid cancer cells

Journal of Interferon and Cytokine Research

Volumn 27, Issue 2, 2007, Pages 129-136

  Naviglio, S ^a   Spina, A ^a   Marra, M ^a   Sorrentino, A ^a   Chiosi, E ^a   Romano, M ^a   Improta, S ^b   Budillon, A ^c   Illiano, G ^a   Abbruzzese, A ^a   Caraglia, M ^c,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b San Gennaro Hospital   (Italy)

^c National Cancer Institute of Naples Fondazione G Pascale   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; ALPHA INTERFERON; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; FORSKOLIN; KT 5720; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENYLATE CYCLASE; APOPTOSIS; BIOLOGICAL RESPONSE MODIFIERS; CARBAZOLES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDOLES; INTERFERON-ALPHA; PYRROLES; SIGNAL TRANSDUCTION;

EID: 33847129726     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.0101     Document Type: Article

References (43)

1. Gutterman JU. Cytokine therapeutics: lessons from interferon alpha. Proc. Natl. Acad. Sci. USA. 1994;91:1198-1205.
2. Vlock DR, Andersen J, Kalish LA, Johnson JT, Kirkwood JM, Whiteside T, Herberman RB, Adams GS, Oken MM, Haselow RE. Phase 11 trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates. J. Immunother. Emphasis Tumor Immunol. 1996;19:433-442.
3. Agarwala SS, Kirkwood JM. Adjuvant therapy of melanoma. Semin. Surg. Oncol. 1998;14:302-310.
4. Rodriguez-Villanueva J, McDonnell TJ. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha. Int. J. Cancer 1995;61:110-114.
5. Caraglia M, Abbruzzese A, Leardi A, Pepe S, Budillon A, Baldassarre G, Selleri C, De Lorenzo S, Fabbrocini A, Giuberti G, Vitale G, Lupoli G, Bianco AR, Tagliaferri P. Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen-activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ. 1999;6:773-780.
6. Roth W, Wagenknecht B, Dichgans J, Weller MJ. Interferon alpha enhances CD95L-induced apoptosis of human malignant glioma cells. J. Neuroimmunol. 1998;87:121-129.
7. Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S, Schreiber RD, Tsujimoto Y, Taniguchi T. Type 1 interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells. 1998;3:29-37.
8. Tilly JL, Billig H, Kowalski KI, Hsueh AJ. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol. Endocrinol. 1992;6:1942-1950.
9. Peng H, Wen TC, Tanaka J, Maeda N, Matsuda S, Desaki J, Sudo S, Zhang B, Sakanaka M. Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries. J. Cereb. Blood Flow Metab. 1998;18:349-360.
10. Stoll SW, Benedict M, Mitra R, Hiniker A, Elder JT, Nunez G. EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL. Oncogene. 1998;16:1493-1499.
11. Sibilia M, Fleischmann A, Behrens A, Stingl L, Carroll J, Watt FM, Schlessinger J, Wagner EF. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 2000;102:211-220.
12. Budillon A, Tagliaferri P, Caraglia M, Torrisi MR, Normanno N, Iacobelli S, Palmieri G, Stoppelli MP, Frati L, Bianco AR. Up-regulation of epidermal growth factor receptor induced by alpha interferon in human epidermoid cancer cells. Cancer Res. 1991;51:1294-1299.
13. Caraglia M, Leardi A, Corradino S, Ciardiello F, Budillon A, Guardasi R, Bianco AR, Tagliaferri P. Alpha-interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells. Int. J. Cancer 1995;61:342-347.
14. Caraglia M, Tagliaferri P, Marra M, Giuberti G, Budillon A, Gennaro ED, Pepe S, Vitale G, Improta S, Tassone P, Venuta S, Bianco AR, Abbruzzese A. EGF activates an inducible survival response via the RAS Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells. Cell Death Differ. 2003;10:218-229.
15. Soeder KJ, Snedden SK, Cao W, Della Rocca GJ, Daniel KW, Luttrell LM, Collins S. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J. Biol. Chem. 1999;274:12017-12022.
16. Dumont JE, Jauniaux JC, Roger PP. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 1989;14:67-71.
17. Dhanasekaran N, Prasad MV. G protein subunits and cell proliferation. Biol. Signals Recept. 1998;7:109-117.
18. Smit MJ, Verzijl D, Iyengar R. Identity of adenylyl cyclase isoform determines the rate of cell cycle progression in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 1998;95:15084-15089.
19. Hanoune J, Pouille Y, Tzavara E, Shen T, Lipskaya L, Miyamoto N, Suzuki Y, Defer N. Adenylyl cyclases: structure, regulation and function in an enzyme superfamily. Mol. Cell. Endocrinol. 1997;128:179-194.
20. Watts VJ, Neve KA. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacol. Ther. 2005;106:405-421.
21. Vaudry D, Stork PJ, Lazarovici P, Eiden LE. Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002;296:1648-1649.
22. Stork PJS, Schmitt JM. Crosstalk between cAMP and MAP kinase signalling in the regulation of cell proliferation. Trends Cell. Biol. 2002;12:258-266.
23. Koehler JA, Yusta B, Drucker DJ. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways. Mol. Endocrinol. 2005;19:459-473.
24. Naviglio S, Pagano M, Romano M, Sorrentino A, Fusco A, Illiano F, Chiosi E, Spina A, Illiano G. Adenylate cyclase regulation via proteasome-mediated modulation of Galphas levels. Cell Signal. 2004;16:1229-1237.
25. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal. Biochem. 1974;58:541-548.
26. Pagano M, Naviglio S, Spina A, Chiosi E, Castoria G, Romano M, Sorrentino A, Illiano F, Illiano G. Differentiation of H9c2 cardiomyoblasts: the role of adenylate cyclase system. J. Cell. Physiol. 2004;198:408-416.
27. Taussig R, Gilman AG. Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 1995;270:1-4.
28. 1- adrenoceptor-linked phosphoinositide metabolism in cultured glia: involvement of protein phosphatases and kinases. Cell. Signal. 2003;15:403-412.
29. David M, Zhou G, Pine R, Dixon JE, Larner AC. The SH2 domain-containing tyrosine phosphatase PTPID is required for interferon alpha/beta-induced gene expression. J. Biol. Chem. 1996;271:15862-15865.
30. Ogawa K, Tashima M, Takeda Y, Sawai H, Toi T, Sawada H, Maruyama Y, Okuma M. Erythroid differentiation and growth inhibition of K562 cells by 2′,5′-dideoxyadenosine: synergism with interferon-alpha. Leuk. Res. 1995;19:749-755.
31. 2. J. Neuroimmunol. 2004;156:107-112.
32. Mullet D, Fertel RH, Kniss D, Cox GW. An increase in intracellular cyclic AMP modulates nitric oxide production in IFN-gamma-treated macrophages. J. Immunol. 1997;158:897-904.
33. Higuchi T, Hannigan GE, Malkin D, Yeger H, Williams BR. Enhancement by retinoic acid and dibutyryl cyclic adenosine 3′,5′-monophosphate of the differentiation and gene expression of human neuroblastoma cells induced by Interferon. Cancer Res. 1991;51:3958-3964.
34. Okutani T, Nishi N, Kagawa Y, Takasuga H, Takenaka I, Usui T, Wada F. Role of cyclic AMP and polypeptide growth regulators in growth inhibition by interferon in PC-3 cells. Prostate 1991;18:73-80.
35. Liu L, Wang Y, Fan Y, Li CL, Chang ZL. IFN-γ activates cAMP/PKA/CREB signaling pathway in murine peritoneal macrophages. J. Interferon Cytokine Res. 2004;24:334-342.
36. Suhara W, Yoneyuma M, Kitabayashi I, Fujita T. Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. J. Biol. Chem. 2002;277:22304-22313.
37. Vo N, Goodman RH. CREB-binding protein and P300 in transcriptional regulation. J. Biol. Chem. 2001;276:13505-13508.
38. El Btaouri H, Rath G, Morjani H, Schneider C, Petitfrere E, Antonicelli F, Martiny L. Interleukin-1 beta-induced apoptosis through adenylyl cyclase and ERK1/2 inhibition in primary cultured thyroid cells. Biochem. Biophys. Res. Commun. 2006;339:469-476.
39. Naviglio S, Spina A, Chiosi E, Fusco A, Illiano F, Pagano M, Romano M, Senatore G, Sorrentino A, Sorvillo L, Illiano G. Inorganic phosphate inhibits growth of human osteosarcoma U2OS cells via adenylate cyclase/cAMP pathway. J. Cell. Biochem. 2006;98:1584-1596.
40. Slot KA, de Boer-Brouwer M, Houweling M, Vaandrager AB, Dorrington JH, Teerds KJ. Luteinizing hormone inhibits Fas-induced apoptosis in ovarian surface epithelial cell lines. J. Endocrinol. 2006;188:227-239.
41. Zhang J, Bui TN, Xiang J, Lin A. Cyclic AMP Inhibits p38 Activation via CREB-Induced Dynein Light Chain. Mol. Cell. Biol. 2006;26:1223-1234.
42. Boccellino M, Giuberti G, Quagliuolo L, Marra M, D'alessandro AM, Fujita H, Giovane A, Abbruzzese A, Caraglia M. Apoptosis Induced by Interferon-a and Antagonized by EGF Is Regulated by Caspase-3-Mediated Cleavage of Gelsolin in Human Epidermoid Cancer Cells. J. Cell. Physiol. 2004;201:71-83.
43. Budillon A, Di Gennaro E, Caraglia M, Barbarulo D, Abbruzzese A, Tagliaferri P. 8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor. Br. J. Cancer 1999;81:1134-1141.